LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed May 1, 2013
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Other
Common Stock
2013-04-30$0.71/sh+11,988$8,511→ 101,491 total
Footnotes (1)
- [F1]Shares acquired under the Peregrine employee stock purchase plan on April 30, 2013.